EMILY HUNEKE: Open Payments
NPI 1194554766 · ASHBURN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$977 in 51 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $738 · 2025 $977
Food & beverage: $977
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $397 |
| Collegium Pharmaceutical, Inc. | 15 | $178 |
| Valinor Pharma, LLC | 7 | $122 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $81 |
| Lilly USA, LLC | 2 | $48 |
| Novo Nordisk Inc | 2 | $41 |
| ABBVIE INC. | 2 | $34 |
| PFIZER INC. | 1 | $23 |
| Averitas Pharma Inc. | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
Products named: RELISTOR, XTAMPZA, MOVANTIK, JOURNAVX, ZEPBOUND, Wegovy, NURTEC ODT, QUTENZA.
Industry payments across VA — which companies pay providers there.
